Uranium prices stayed fairly steady in 2025, but experts agree its long-term outlook is compelling, Demand picked up from reactor restarts, new nuclear construction...
InMed Pharmaceuticals Inc. (NASDAQ: INM) (‘InMed’ or the ‘Company’), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for...
After a year marked by policy changes and trade uncertainty, experts are calling for cleantech investment to be dominated by artificial intelligence (AI) energy...
Sister Stephanie Schmidt had a hunch about what her fellow nuns would discuss over dinner at their Erie, Pennsylvania, monastery on Wednesday night. The...
American Uranium Limited (ASX:AMU, OTC:AMUIF) (American Uranium, AMU or the Company) is pleased to advise that 2025 resource expansion drilling at its Lo Herma...
Group Eleven Resources Corp. (TSXV: ZNG,OTC:GRLVF) (OTCQB: GRLVF) (FSE: 3GE) (‘Group Eleven’ or the ‘Company’) announces that it has granted 2,600,000 incentive stock options...
MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx in recurrent pericarditis is fully funded through to a planned New Drug Application submission...
Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for traders, including mining and defense stocks, reports on how critical mineral antimony is gaining...
Silver’s performance in 2025 is drawing attention to silver-mining companies as investors look to gain exposure to the metal’s success. During Q3 2025, the...
The cleantech sector experienced a dynamic third quarter, with predictions of volatility coming to fruition. While global investment in renewable energy is strong, notable...
Australian Prime Minister Anthony Albanese and US President Donald Trump signed a rare earths deal during their meeting at the White House on Monday...